Department of Surgical Sciences, Sapienza University of Rome, V.le Regina Elena n 324, 00161, Rome, Italy.
Int J Colorectal Dis. 2013 Feb;28(2):261-6. doi: 10.1007/s00384-012-1571-y. Epub 2012 Aug 30.
Radiation proctitis is a known complication following radiation therapy for pelvic malignancy. The majority of cases are treated nonsurgically. Rectal instillation of formalin solution has been described as a successful treatment for chronic radiation-induced hemorrhagic proctitis resistant to medical treatment. We present our results in patients undergoing treatment with application of 4 % formalin for radiation-induced injury to the rectum.
All patients were treated under anesthesia by direct application of 4 % formalin solution to the affected rectal areas. Patient gender, initial malignancy, grade of proctitis, need for blood transfusion, previous therapy, number of applications and response to treatment with formalin, complications, and length of follow-up were reviewed.
A total of 15 patients with a mean age of 68.9 (range, 48-77) years were followed for 31.3 (range, 18-51) months. The mean interval from the conclusion of radiotherapy and the onset of symptoms was 6.9 months. The mean duration of hemorrhagic proctitis before formalin application was 7.9 months. Ten patients had only one formalin application and five patients required a second application because of the persistent bleeding. Thirteen patients (87 %) had complete cessation of bleeding. No complications related to the formalin treatment were observed.
According to a revision of the literature and our experience, despite the small number of patients in our trial, we can state that the application of 4 % formalin solution is an effective, safe, and well-tolerated treatment for chronic radiation-induced hemorrhagic proctitis with minimal discomfort and no severe complications.
放射性直肠炎是盆腔恶性肿瘤放射治疗后的已知并发症。大多数病例采用非手术治疗。直肠内灌入福尔马林溶液已被描述为治疗对药物治疗有抵抗力的慢性放射性出血性直肠炎的成功方法。我们介绍了在接受直肠放射性损伤治疗时应用 4%福尔马林的患者的结果。
所有患者均在麻醉下通过直接将 4%福尔马林溶液应用于受影响的直肠区域进行治疗。回顾患者的性别、初始恶性肿瘤、直肠炎的严重程度、是否需要输血、先前的治疗、应用次数和对福尔马林治疗的反应、并发症以及随访时间。
共有 15 名平均年龄为 68.9 岁(范围 48-77 岁)的患者接受了 31.3 个月(范围 18-51 个月)的随访。从放疗结束到症状出现的平均间隔为 6.9 个月。应用福尔马林前出血性直肠炎的平均持续时间为 7.9 个月。10 名患者仅进行了一次福尔马林应用,5 名患者由于持续出血需要第二次应用。13 名患者(87%)的出血完全停止。未观察到与福尔马林治疗相关的并发症。
根据文献复习和我们的经验,尽管我们的试验中患者人数较少,但我们可以说应用 4%福尔马林溶液是治疗慢性放射性出血性直肠炎的有效、安全且耐受性良好的方法,患者仅有轻微不适且无严重并发症。